Ventru™
is an early-stage medical device company developing neurosurgical innovations that improve safety and accessibility, leading to better patient outcomes and lower healthcare costs.

Ventru's novel Device for Intraventricular Entry (DIVE) assists surgeons with the safe placement of drains for patients suffering from hydrocephalus.

Hydrocephalus leads to increased intracranial pressure and an external ventricular drain (EVD) or ventricular-peritoneal shunt (VPS) is needed to drain excess CSF. However, the success of EVD/VPS requires accurate catheter placement. ​Currently, freehand techniques using anatomical landmarks have a variable success rate as low as 40%, requiring multiple catheter passes. Additionally, existing devices are cumbersome, non-adjustable, require a large incision, and have a tendency to allow catheter migration following placement.

Accuracy impacts patient outcomes.

.Patients are at increased risk of hemorrhage, infection, delayed CSF draining, increased intracranial pressure and death.

---

Current freehand techniques:

Have a 40%
misplacement rate

Are a difficult procedure at bedside
head instability, awake patient, poor lighting

Have a 1.4 to 3 
​passes to procedure ratio

Ventru​ is improving the safety and accessibility of neurosurgery through device innovation.

Our stereotactic guide assists in the placement ​of ventricular catheters when an EVD or shunt is clinically required.

Orthogonal Trajectory

Device enables alignment with the lateral ventricle for accurate placement 

Low Profile & Secure

Device is secured underneath the skin enabling the surgeon to use both hands for the procedure

Accommodates Existing Tools

Single use device designed to be compatible with standard catheters, drills, and other tools

Contact Us

[email protected]
3401 Grays Ferry Ave, Building 450, Suite 1076, Philadelphia PA 19146